Your browser doesn't support javascript.
loading
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck, Wasco; Bremmer, Felix; Kotthoff, Mara; Fichtner, Alexander; Skowron, Margaretha A; Schönberger, Stefan; Calaminus, Gabriele; Vokuhl, Christian; Pfister, David; Heidenreich, Axel; Albers, Peter; Adjaye, James; Nettersheim, Daniel.
Afiliação
  • Wruck W; Institute for Stem Cell Research and Regenerative Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Bremmer F; Institute of Pathology, University Medical Center Goettingen, Goettingen, Germany.
  • Kotthoff M; Department of Urology, Urological Research Lab, Translational UroOncology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Fichtner A; Institute of Pathology, University Medical Center Goettingen, Goettingen, Germany.
  • Skowron MA; Department of Urology, Urological Research Lab, Translational UroOncology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Schönberger S; Department of Pediatric Hematology and Oncology, University Children's Hospital, Essen, Germany.
  • Calaminus G; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Vokuhl C; Institute of Pathology, University Hospital Bonn, Bonn, Germany.
  • Pfister D; Department of Urology, University Hospital Cologne, Cologne, Germany.
  • Heidenreich A; Department of Urology, University Hospital Cologne, Cologne, Germany.
  • Albers P; Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Adjaye J; Institute for Stem Cell Research and Regenerative Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Nettersheim D; Department of Urology, Urological Research Lab, Translational UroOncology, University Hospital Düsseldorf, Düsseldorf, Germany.
J Cell Mol Med ; 25(3): 1394-1405, 2021 02.
Article em En | MEDLINE | ID: mdl-33448076

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas Oncogênicas / Tumor do Seio Endodérmico / Fator 3-beta Nuclear de Hepatócito Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas Oncogênicas / Tumor do Seio Endodérmico / Fator 3-beta Nuclear de Hepatócito Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article